Utility of Metagenomic Next-Generation Sequencing in Infective Endocarditis: A Systematic Review
- PMID: 36551455
- PMCID: PMC9774888
- DOI: 10.3390/antibiotics11121798
Utility of Metagenomic Next-Generation Sequencing in Infective Endocarditis: A Systematic Review
Abstract
Blood cultures have been the gold standard for identifying pathogens in infective endocarditis (IE). Blood culture-negative endocarditis (BCNE), however, occurs in 40% or more of IE cases with the bulk of them due to recent antibiotic exposure prior to obtaining blood cultures. Increasingly, molecular techniques are being used for pathogen identification in cases of BCNE and more recently has included metagenomic next-generation sequencing (mNGS). We therefore performed a literature search on August 31, 2022, that assessed the mNGS in IE and 13 publications were identified and included in a systematic review. Eight (61.5%) of them focused only on IE with mNGS performed on cardiac valve tissue in four studies, plasma in three studies and cardiac implantable electronic devices (CIED) in one study. Gram-positive cocci, including Staphylococcus aureus (n = 31, 8.9%), coagulase-negative staphylococci (n = 61, 17.6%), streptococci (n = 130, 37.5%), and Enterococcus faecalis (n = 23, 6.6%) were the predominant organisms identified by mNGS. Subsequent investigations are needed to further define the utility of mNGS in BCNE and its impact on patient outcomes. Despite some pitfalls, mNGS seems to be of value in pathogen identification in IE cases, particularly in those with BCNE. This study was registered and on the Open Science Framework platform.
Keywords: cardiovascular implantable electronic devices; device-related infections; diagnosis; infective endocarditis; metagenomic next-generation sequencing; molecular.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Miller J.M., Binnicker M.J., Campbell S., Carroll K.C., Chapin K.C., Gilligan P.H., Gonzalez M.D., Jerris R.C., Kehl S.C., Patel R., et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin. Infect. Dis. 2018;67:813–816. doi: 10.1093/cid/ciy584. - DOI - PubMed
-
- Baddour L.M., Wilson W.R., Bayer A.S., Fowler V.G., Jr., Tleyjeh I.M., Rybak M.J., Barsic B., Lockhart P.B., Gewitz M.H., Levison M.E., et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015;132:1435–1486. doi: 10.1161/CIR.0000000000000296. - DOI - PubMed
-
- Lamas C.C., Fournier P.E., Zappa M., Brandão T.J., Januário-da-Silva C.A., Correia M.G., Barbosa G.I., Golebiovski W.F., Weksler C., Lepidi H., et al. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases. Infection. 2016;44:459–466. doi: 10.1007/s15010-015-0863-x. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
